Perioperative medicine & outcomes

Optimal multimodal analgesia combinations to reduce pain and opioid use following non-cardiac surgery: an instrumental variable analysis

Reg Anesth Pain MedPublished Retrospective cohort study

Authors' conclusion

Our findings further support existing evidence on the effectiveness of MMA in reducing postoperative pain and opioid use following non-cardiac surgery.

Study context

Population
Patients undergoing elective non-cardiac surgery with GA at six Veterans Health Administration hospitals, 2017–2022
Participants
23,238 procedures
Exposure
MMA vs no MMA; non-opioid medication combinations
Outcome
Self-reported pain and opioid use after surgery
Methodological detailsinstrumental variable analysis, multicentre
  • Instrumental variable analysis
  • Multicentre

Main finding

As reported in the abstract

Difference

6.8 fewer OMEs

95% CI −10.2, to −3.4

inpatients, postoperative opioid use; Instrumental variable (IV) analysis

Difference

1.0 unit lower

95% CI −1.6 to −0.4

outpatients, postoperative pain scores; IV analysis

Received MMA
46.1%

Observational data: associations, not effects.

Further findings

Postoperative opioid use by non-opioid combination

Mean reduction (OMEs) (95% CI)
NSAIDs plus dexamethasone−29.5 (−36.9 to −19.5)
NSAIDs plus RA−28.4 (−40.1 to −16.8)
Greatest reductions in postoperative opioid use

Characteristics of MMA recipients

MMA more common in younger patients, females and those with lower probability of mortality

Original publication

Optimal multimodal analgesia combinations to reduce pain and opioid use following non-cardiac surgery: an instrumental variable analysis. Reg Anesth Pain Med. Published 13 July 2025. doi:10.1136/rapm-2025-106720

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.